Laboratoire CarMeN, INSERM U-1060, INRAE U-1397, Université Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France.
Laboratoire CarMeN, INSERM U-1060, INRAE U-1397, Université Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France; Département Endocrinologie, Diabète et Nutrition, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France.
Cell Calcium. 2023 Sep;114:102780. doi: 10.1016/j.ceca.2023.102780. Epub 2023 Jul 15.
The flexibility between the wide array of hepatic functions relies on calcium (Ca) signalling. Indeed, Ca is implicated in the control of many intracellular functions as well as intercellular communication. Thus, hepatocytes adapt their Ca signalling depending on their nutritional and hormonal environment, leading to opposite cellular functions, such as glucose storage or synthesis. Interestingly, hepatic metabolic diseases, such as obesity, type 2 diabetes and non-alcoholic fatty liver diseases, are associated with impaired Ca signalling. Here, we present the hepatocytes' toolkit for Ca signalling, complete with regulation systems and signalling pathways activated by nutrients and hormones. We further discuss the current knowledge on the molecular mechanisms leading to alterations of Ca signalling in hepatic metabolic diseases, and review the literature on the clinical impact of Ca-targeting therapeutics.
肝脏功能的多样性依赖于钙(Ca)信号。事实上,Ca 参与了许多细胞内功能以及细胞间通讯的控制。因此,肝细胞根据其营养和激素环境来调节 Ca 信号,从而导致相反的细胞功能,如葡萄糖储存或合成。有趣的是,肝脏代谢疾病,如肥胖、2 型糖尿病和非酒精性脂肪性肝病,与 Ca 信号受损有关。在这里,我们介绍了肝细胞的 Ca 信号工具箱,包括营养物质和激素激活的调节系统和信号通路。我们还进一步讨论了导致肝脏代谢疾病中 Ca 信号改变的分子机制的现有知识,并回顾了关于钙靶向治疗的临床影响的文献。